TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing a target-first and rational molecular glue discovery platform to address difficult to drug disease targets, today announced that Dr. Patrick Trojer, President and Chief Executive Officer, will present at the UBS Biotechnology Private Company Virtual Symposium on Wednesday September 20, 2023 at 3:30 PM ET.
The stock price of UBS Group AG (NYSE: UBS) has plunged by -0.08 when compared to previous closing price of 26.02, but the company has seen a 1.48% gain in its stock price over the last five trading sessions. Accesswire reported 2023-09-18 that LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIAN
SAN DIEGO (BUSINESS WIRE) Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today participation in the following upcoming investor conferences:Morgan Stanley 21st Annual Global Healthcare Conference, September 11-13, 2023, NY, NY:Pipeline management.
/PRNewswire/ Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying.